Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Development of a new pharmacokinetic model incorporating nasal physiologic function to predict nasal drug absorption

  • At: 2014 FIP Congress in PSWC, Melbourne (Australia)
  • Type: Presentation
  • By: INOUE, Daisuke (Shujitsu University, School of Pharmacy, Okayama, Japan)
  • Co-author(s): Furubayashi, Tomoyuki (Shujitsu University, Okayama, Japan)
    Ogawara, Ken-Ichi (Okayama University, Okayama, Japan)
    Kimura, Toshikiro (Okayama University, Okayama, Japan)
    Higaki, Kazutaka (Okayama University, Okayama, Japan)
    Katsumi, Hidemasa (Kyoto Pharmaceutical University, Kyoto, Japan)
    Sakane, Toshiyasu (Kyoto Pharmaceutical University, Kyoto, Japan)
    Yamamoto, Akira (Kyoto Pharmaceutical University, Kyoto, Japan)
    Niwa, Toshiro (Shujitsu University, Okayama, Japan)
  • Abstract:

    Background
    Advantages of nasal drug delivery include rapid absorption and avoidance of presystemic metabolism. In addition, nasal drug delivery is non-invasive which improve the patient compliance.
    Aims
    Although the nasal route has attracted much attention as a systemic delivery route, only a few nasal formulations are on the market now. To..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses